Geneva, June 16 -- International Clinical Trials Registry received information related to the study (NCT07005297) titled 'Clinical Genetics Branch Eligibility Screening Survey' on June 4.
Study Type: Observational
Primary Sponsor: National Cancer Institute (NCI)
Condition:
Melanoma
Li-Fraumeni Syndrome
Pulmonary Blastoma
Chordoma
Congenital Bone Marrow Failure Syndromes
Costello Syndrome
Fanconi Anemia
CFC Syndrome (CFCS)
Legius Syndrome
RASopathies
Recruitment Status: Not recruiting
Date of First Enrollment: June 11, 2025
Target Sample Size: 1000
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/ct2/show/NCT07005297
Published by HT Digital Content Services with permission from Health Dail...